Immunovant, Inc. (IMVT) Net Income by Year
Immunovant, Inc. reported a net loss of $505.6M in fiscal year 2026. This represents a decrease of 22.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2019 to 2026, and the quarters Immunovant, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMVT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IMVT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Immunovant, Inc. financials
Frequently Asked Questions
What was Immunovant, Inc.'s net income in fiscal year 2026?
Immunovant, Inc. reported a net loss of $505.6M in fiscal year 2026.
How fast is Immunovant, Inc.'s net income growing?
Immunovant, Inc. (IMVT) net income fell by 22.2% year over year, from -$413.8M to -$505.6M in fiscal year 2026.
How has Immunovant, Inc.'s net income changed over the years?
Across the 8 fiscal years this page covers, Immunovant, Inc. (IMVT) net income went from -$28.6M in fiscal year 2019 to -$505.6M in fiscal year 2026.
What was Immunovant, Inc.'s net income in the most recent quarter?
Immunovant, Inc. (IMVT) reported -$153.2M in net income in Q1 2027. This represents a decrease of 27.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Immunovant, Inc. (IMVT) reported on that line in every period on record.